a375 ma2 (ATCC)
Structured Review

A375 Ma2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 60 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a375 ma2/product/ATCC
Average 95 stars, based on 60 article reviews
Images
1) Product Images from "Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling"
Article Title: Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling
Journal: The Journal of Biological Chemistry
doi: 10.1016/j.jbc.2026.111193
Figure Legend Snippet: Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.
Techniques Used: Incubation, Control, Inverted Microscopy, Derivative Assay